Eisai Says Aricept Patent Claim Upheld by Japan Supreme Court
Stock Chart for Eisai Co Ltd (4523)
Eisai’s patent is valid until June 22, 2013, after the court rejected an appeal by generic drugmakers, according to a faxed statement from the Japanese company today.
To contact the reporter on this story: Go Onomitsu in Tokyo at email@example.com
To contact the editor responsible for this story: Kyung Bok Cho at firstname.lastname@example.org
Bloomberg reserves the right to edit or remove comments but is under no obligation to do so, or to explain individual moderation decisions.